icon-folder.gif   Conference Reports for NATAP  
  EASL 46th Annual Meeting
March 30th - April 3rd 2011
Berlin, Germany
Back grey_arrow_rt.gif
In vitro profiling of GSK2336805, A Potent and Selective Inhibitor of HCV NS5A
  Reported by Jules Levin
EASL 2011 March 31-Apr 2 Berlin Germany
J. Bechtel1, R. Crosby1, A. Wang1, E. Woldu1, S. Van Horn2, J. Horton1, K. Remlinger1, K. Creech1, L.H. Carballo1, S. You1, C. Voitenleitner1, J. Vamathevan3, M. Duan1, A. Spaltenstein1, W. Kazmierski1, C. Roberts1and R. Hamatake1 1GlaxoSmithKline, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Upper Providence, PA, USA, 3GlaxoSmithKline, Stevenage, UK EASL International Liver Congress 2011, Berlin, Germany